Zheng D - Search Results

1

2A peptide-based, lentivirus-mediated anti-death receptor 5 chimeric antibody expression prevents tumor growth in nude mice.

Li M, Wu Y, Qiu Y, Yao Z, Liu S, Liu Y, Shi J, Zheng D. Li M, et al. Among authors: zheng d. Mol Ther. 2012 Jan;20(1):46-53. doi: 10.1038/mt.2011.197. Epub 2011 Sep 20. Mol Ther. 2012. PMID: 21934654 Free PMC article.

2

[Construction and expression of anti-tumor necrosis factor related apoptosis-inducing ligand receptor death receptor 5 chimeric antibody in eukaryotic cells].

Chen F, Guo YB, Liu SL, Zheng DX, Liu YX. Chen F, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Dec;30(6):690-5. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008. PMID: 19180918 Chinese.

3

[Killing effects of controllable expression of tumor necrosis factor-related apoptosis-inducing ligand from mesenchymal stem cells on hepatocellular carcinoma cells].

Liu Z, Ma H, Shi J, Zhang YX, Liu YX, Zheng DX. Liu Z, et al. Zhonghua Yi Xue Za Zhi. 2011 Mar 1;91(8):544-8. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21418858 Chinese.

4

[Construction and stable expression of anti-human tumor necrosis factor-related apoptosis-inducing ligand receptor 2 chimeric antibody in CHO cells].

Lv FJ, Shi J, Zhang YX, Liu SL, Liu YX, Zheng DX. Lv FJ, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011 Apr;27(4):415-8. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011. PMID: 21481320 Chinese.

5

[Expression and tumoricidal activity of a human-mouse chimeric anti-DR5 antibody through a Furin/2A peptide].

Li M, Lü FJ, Shi J, Liu YX, Zheng DX. Li M, et al. Zhonghua Yi Xue Za Zhi. 2011 Mar 15;91(10):707-10. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21600181 Chinese.

6

A novel anti-human DR5 monoclonal antibody with tumoricidal activity induces caspase-dependent and caspase-independent cell death.

Guo Y, Chen C, Zheng Y, Zhang J, Tao X, Liu S, Zheng D, Liu Y. Guo Y, et al. Among authors: zheng d, zheng y. J Biol Chem. 2005 Dec 23;280(51):41940-52. doi: 10.1074/jbc.M503621200. Epub 2005 Oct 18. J Biol Chem. 2005. PMID: 16234248 Free article.

7

Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice.

Ma H, Liu Y, Liu S, Xu R, Zheng D. Ma H, et al. Among authors: zheng d. Hepatology. 2005 Dec;42(6):1355-63. doi: 10.1002/hep.20918. Hepatology. 2005. PMID: 16317690

8

Therapeutic expression of an anti-death receptor 5 single-chain fixed-variable region prevents tumor growth in mice.

Shi J, Liu Y, Zheng Y, Guo Y, Zhang J, Cheung PT, Xu R, Zheng D. Shi J, et al. Among authors: zheng d, zheng y. Cancer Res. 2006 Dec 15;66(24):11946-53. doi: 10.1158/0008-5472.CAN-06-1227. Cancer Res. 2006. PMID: 17178893

9

Formyl peptide receptor-like 1 mediated endogenous TRAIL gene expression with tumoricidal activity.

Lin C, Wei W, Zhang J, Liu S, Liu Y, Zheng D. Lin C, et al. Among authors: zheng d. Mol Cancer Ther. 2007 Oct;6(10):2618-25. doi: 10.1158/1535-7163.MCT-07-0286. Mol Cancer Ther. 2007. PMID: 17938258

10

Sp1 is involved in 8-chloro-adenosine-upregulated death receptor 5 expression in human hepatoma cells.

Sun M, Zhang J, Liu S, Liu Y, Zheng D. Sun M, et al. Among authors: zheng d. Oncol Rep. 2008 Jan;19(1):177-85. Oncol Rep. 2008. PMID: 18097593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,979 results

Search Page

Filters